Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.
Open Forum Infect Dis. 2015 May 5;2(2):ofv040. doi: 10.1093/ofid/ofv040. eCollection 2015 Apr.
Open Forum Infect Dis. 2015.
PMID: 26380340
Free PMC article.
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects.
Greenberg RN, Hay CM, Stapleton JT, Marbury TC, Wagner E, Kreitmeir E, Röesch S, von Krempelhuber A, Young P, Nichols R, Meyer TP, Schmidt D, Weigl J, Virgin G, Arndtz-Wiedemann N, Chaplin P.
Greenberg RN, et al. Among authors: arndtz wiedemann n.
PLoS One. 2016 Jun 21;11(6):e0157335. doi: 10.1371/journal.pone.0157335. eCollection 2016.
PLoS One. 2016.
PMID: 27327616
Free PMC article.
Clinical Trial.
Item in Clipboard
Cardiac safety of Modified Vaccinia Ankara for vaccination against smallpox in a young, healthy study population.
Zitzmann-Roth EM, von Sonnenburg F, de la Motte S, Arndtz-Wiedemann N, von Krempelhuber A, Uebler N, Vollmar J, Virgin G, Chaplin P.
Zitzmann-Roth EM, et al. Among authors: arndtz wiedemann n.
PLoS One. 2015 Apr 16;10(4):e0122653. doi: 10.1371/journal.pone.0122653. eCollection 2015.
PLoS One. 2015.
PMID: 25879867
Free PMC article.
Item in Clipboard
A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.
Greenberg RN, Hurley MY, Dinh DV, Mraz S, Vera JG, von Bredow D, von Krempelhuber A, Roesch S, Virgin G, Arndtz-Wiedemann N, Meyer TP, Schmidt D, Nichols R, Young P, Chaplin P.
Greenberg RN, et al. Among authors: arndtz wiedemann n.
PLoS One. 2015 Oct 6;10(10):e0138348. doi: 10.1371/journal.pone.0138348. eCollection 2015.
PLoS One. 2015.
PMID: 26439129
Free PMC article.
Clinical Trial.
Item in Clipboard
Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.
Greenberg RN, Hurley MY, Dinh DV, Mraz S, Vera JG, von Bredow D, von Krempelhuber A, Roesch S, Virgin G, Arndtz-Wiedemann N, Meyer TP, Schmidt D, Nichols R, Young P, Chaplin P.
Greenberg RN, et al. Among authors: arndtz wiedemann n.
PLoS One. 2015 Nov 10;10(11):e0142802. doi: 10.1371/journal.pone.0142802. eCollection 2015.
PLoS One. 2015.
PMID: 26554703
Free PMC article.
No abstract available.
Item in Clipboard
Myocardial effects of IMVAMUNE.
Arndtz-Wiedemann N.
Arndtz-Wiedemann N.
Biosecur Bioterror. 2014 Jul-Aug;12(4):217-8. doi: 10.1089/bsp.2014.0037.
Biosecur Bioterror. 2014.
PMID: 25054563
No abstract available.
Item in Clipboard
Cite
Cite